Anatol Kreitzer
Chief Discovery Officer · MapLight Therapeutics, Inc.
- 2025
- Oct 16, 2026
- 8
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Anatol Kreitzer files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Catalyst4, Inc. - $98.71M in MPLT purchases and sales in the last 12 months
- Christopher A. Kroeger - $13.14M in MPLT purchases and sales in the last 12 months
- Jonathan Gillis - $3.64M in MPLT purchases and sales in the last 12 months
- Erin Pennock Foff - $3.50M in MPLT purchases and sales in the last 12 months
- James Woodruff Lillie - $2.65M in MPLT purchases and sales in the last 12 months
- Kristopher Hanson - $1.73M in MPLT purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Anatol Kreitzer?
Anatol Kreitzer is a corporate insider, tracked as Chief Discovery Officer of MapLight Therapeutics, Inc. (MPLT). InsiderAlpha holds 8 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Anatol Kreitzer submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Anatol Kreitzer been buying or selling stock?
Recorded transactions: 0 open-market purchases and 12 open-market sales ($2.88M) across all tracked filings.
